Conclusion: By exploiting tumor GSH overexpression-activated photodynamic therapy, the NTP-NO2 depletes GSH and promotes caspase-1/GSDMD pathway to trigger robust pyroptosis, eliciting inflammatory/immune responses both in vitro and in vivo. The gene discussed is CASP1; the disease is neoplasm.